RNS Number:4378J
ReGen Therapeutics PLC
31 March 2003

Result of EGM
London, England - 31 March 2003


                             REGEN THERAPEUTICS PLC

                    Results of Extraordinary General Meeting


ReGen Therapeutics Plc ("ReGen" or "the Company") announces that at the
Extraordinary General Meeting of the Company held earlier today (the "EGM"),
Shareholders passed all of the resolutions proposed including those relating to
the capital reorganisation, as detailed in the circular sent to shareholders
dated 7 March 2003 (the "Capital Reorganisation").

It is anticipated that the Capital Reorganisation will take effect tomorrow, 
1 April 2003, whereupon the new ordinary shares of 0.1p each arising on the
Capital Reorganisation (the "New Ordinary Shares") will be admitted to trading
on the Alternative Investment Market of the London Stock Exchange plc ("AIM").

Replacement certificates will not be sent out in relation to the New Ordinary
Shares as existing share certificates will remain valid in relation to the
number of New Ordinary Shares that each shareholder is entitled to following the
Capital Reorganisation. Certificates will not be issued for the deferred shares
of 4.9p each arising on the Capital Reorganisation. Shareholders who currently
hold their existing ordinary shares in ReGen in uncertificated form will have
their CREST accounts credited with the New Ordinary Shares following their
admission to AIM.  The Deferred Shares will not be eligible for settlement
through CREST.


For further information please contact:

Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EGMUARNROAROOAR